U.S. Food and Drug Administration
Skip navigationFDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
rule

Menopause & Hormones

flowerWorking in collaboration with the National Institutes of Health and other Department of Health and Human Services agencies, FDA has developed science-based informational materials on its latest guidance on menopausal hormone therapies (estrogens and estrogens with progestins), and is working closely with women's health organizations, community-based organizations, and other experts to get this information out to women and health-care providers.

Read the Press Release about the Campaign (Sept. 9, 2003)

Listen to the Hormone Replacement
Therapy Radio Spots (Sept. 17, 2003):

Sponsoring Organizations

Brochure

Purse Guide

To order printed copies, contact:
National Women's Health Information Center
1-800-994-9662
TDD: 1-888-220-5446
www.4woman.gov

What's New

September Is National Menopause Awareness Month

Menostar: New Drug for Postmenopausal Women

FDA Evaluating Latest Study on Estrogen Use

New Labeling for Estrogen/Progestin Products:

rule

FDA Office of Women's Health:

OWH Library: Menopause & Hormones section

OWH Update (newsletter)

rule

More Information:

Menopause & Hormone Therapy Page
National Women's Health Information Center

Menopausal Hormone Therapy Information
National Institutes of Health

Menopause Questions & Answers
National Cancer Institute

Hormone Replacement Therapy
National Library of Medicine

Postmenopausal Hormone Therapy
National Heart, Lung, and Blood Institute

 


rule


FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Office of Women's Health